Monday, November 01, 2010

Significant portion of children received antipsychotic for conditions that have no published evidence supporting their use

A significant proportion of children younger than 18 years in at least 1 state Medicaid population received a second-generation antipsychotic for conditions that have no published evidence supporting their use. "Clearly, behavioural problems, including oppositional and conduct disorders and hyperkinetic-hyperactivity symptoms, were frequently seen among the children treated with second-generation antipsychotics," the investigators write. [http://www.medscape.com/viewarticle/717544]

 

No comments: